Inflammation and exercise: Inhibition of monocytic intracellular TNF production by acute exercise via β2-adrenergic activation

Brain, Behavior, and Immunity

Volumn 61, Issue , 2017, Pages 60-68

  Dimitrov, Stoyan ^a   Hulteng, Elaine ^a   Hong, Suzi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenergic agonist; Beta blocker; Cytokine regulation; Exercise; Sympathetic activation

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; EPINEPHRINE; ISOPRENALINE; LIPOPOLYSACCHARIDE; NORADRENALIN; TUMOR NECROSIS FACTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOKINE;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EC50; ENZYME ACTIVATION; ENZYME INHIBITION; EXERCISE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MONOCYTE; NORMAL HUMAN; PROTEIN BLOOD LEVEL; BLOOD; DRUG EFFECT; INFLAMMATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ADULT; CYTOKINES; EPINEPHRINE; EXERCISE; FEMALE; HUMANS; INFLAMMATION; ISOPROTERENOL; MALE; MIDDLE AGED; MONOCYTES; NOREPINEPHRINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85009174934     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.12.017     Document Type: Article

References (60)

1. Baker, J.G., The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br. J. Pharmacol. 144 (2005), 317–322.
2. Bellinger, D.L., Millar, B.A., Perez, S., Carter, J., Wood, C., ThyagaRajan, S., Molinaro, C., Lubahn, C., Lorton, D., Sympathetic modulation of immunity: relevance to disease. Cell. Immunol. 252 (2008), 27–56.
3. Berg, A.H., Scherer, P.E., Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96 (2005), 939–949.
4. Borg, G., Perceived exertion as an indicator of somatic stress. Scand. J. Rehabil. Med. 2 (1970), 92–98.
5. Branen, L., Hovgaard, L., Nitulescu, M., Bengtsson, E., Nilsson, J., Jovinge, S., Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 24 (2004), 2137–2142.
6. Dhabhar, F.S., Malarkey, W.B., Neri, E., McEwen, B.S., Stress-induced redistribution of immune cells–from barracks to boulevards to battlefields: a tale of three hormones–Curt Richter Award winner. Psychoneuroendocrinology 37 (2012), 1345–1368.
7. Dimitrov, S., Lange, T., Born, J., Selective mobilization of cytotoxic leukocytes by epinephrine. J. Immunol. 184 (2010), 503–511.
8. Dimitrov, S., Shaikh, F., Pruitt, C., Green, M., Wilson, K., Beg, N., Hong, S., Differential TNF production by monocyte subsets under physical stress: blunted mobilization of pro-inflammatory monocytes in prehypertensive individuals. Brain Behav. Immun. 27C (2013), 101–108.
9. Dimsdale, J.E., Moss, J., Plasma catecholamines in stress and exercise. JAMA 243 (1980), 340–342.
10. Drenth, J.P., Krebbers, R.J., Bijzet, J., Van der Meer, J.W., Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run. Eur. J. Clin. Invest. 28 (1998), 866–872.
11. Elenkov, I.J., Wilder, R.L., Chrousos, G.P., Vizi, E.S., The sympathetic nerve–an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52 (2000), 595–638.
12. Farmer, P., Pugin, J., Beta-adrenergic agonists exert their “anti-inflammatory” effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000), L675–L682.
13. Gleeson, M., Bishop, N.C., Stensel, D.J., Lindley, M.R., Mastana, S.S., Nimmo, M.A., The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat. Rev. Immunol. 11 (2011), 607–615.
14. Goebel, M.U., Mills, P.J., Irwin, M.R., Ziegler, M.G., Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom. Med. 62 (2000), 591–598.
15. Grisanti, L.A., Evanson, J., Marchus, E., Jorissen, H., Woster, A.P., DeKrey, W., Sauter, E.R., Combs, C.K., Porter, J.E., Pro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent. Mol. Immunol. 47 (2010), 1244–1254.
16. Groeneveld, A.B., Beishuizen, A., de Jong, M.F., Catecholamines, parasympathetic stimuli, or cortisol for overwhelming sepsis?. Crit. Care Med. 34 (2006), 1549–1550.
17. Haahr, P.M., Pedersen, B.K., Fomsgaard, A., Tvede, N., Diamant, M., Klarlund, K., Halkjaer-Kristensen, J., Bendtzen, K., Effect of physical exercise on in vitro production of interleukin 1, interleukin 6, tumour necrosis factor-alpha, interleukin 2 and interferon-gamma. Int. J. Sports Med. 12 (1991), 223–227.
18. Hoffmann, C., Leitz, M.R., Oberdorf-Maass, S., Lohse, M.J., Klotz, K.N., Comparative pharmacology of human beta-adrenergic receptor subtypes–characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch. Pharmacol. 369 (2004), 151–159.
19. Hong, S., Mills, P.J., Effects of an exercise challenge on mobilization and surface marker expression of monocyte subsets in individuals with normal vs. elevated blood pressure. Brain Behav. Immun. 22 (2008), 590–599.
20. Hong, S., Johnson, T.A., Farag, N.H., Guy, H.J., Matthews, S.C., Ziegler, M.G., Mills, P.J., Attenuation of T-lymphocyte demargination and adhesion molecule expression in response to moderate exercise in physically fit individuals. J. Appl. Physiol. 98 (2005), 1057–1063.
21. Hong, S., Dimitrov, S., Pruitt, C., Shaikh, F., Beg, N., Benefit of physical fitness against inflammation in obesity: role of beta adrenergic receptors. Brain Behav. Immun. 39 (2014), 113–120.
22. Hong, S., Dimitrov, S., Cheng, T., Redwine, L., Pruitt, C., Mills, P.J., Ziegler, M.G., Green, J.M., Shaikh, F., Wilson, K., Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease. Brain Behav. Immun. 50 (2015), 31–38.
23. Kavelaars, A., van de, P.M, Zijlstra, J., Heijnen, C.J., Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes. J. Neuroimmunol. 77 (1997), 211–216.
24. Kennedy, B., Bigby, T.D., Ziegler, M.G., Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels. J. Clin. Invest. 95 (1995), 2896–2902.
25. Kennedy, B., Ziegler, M.G., A more sensitive and specific radioenzymatic assay for catecholamines. Life Sci. 47 (1990), 2143–2153.
26. Kiechl, S., Egger, G., Mayr, M., Wiedermann, C.J., Bonora, E., Oberhollenzer, F., Muggeo, M., Xu, Q., Wick, G., Poewe, W., Willeit, J., Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 103 (2001), 1064–1070.
27. Kollias, G., Douni, E., Kassiotis, G., Kontoyiannis, D., On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 169 (1999), 175–194.
28. Madden, K.S., Catecholamines, sympathetic innervation, and immunity. Brain Behav. Immun. 17:Suppl. 1 (2003), S5–S10.
29. Maisel, A.S., Fowler, P., Rearden, A., Motulsky, H.J., Michel, M.C., A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment. Clin. Pharmacol. Ther. 46 (1989), 429–439.
30. Maisel, A.S., Harris, T., Rearden, C.A., Michel, M.C., Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individuals and patients with congestive heart failure. Circulation 82 (1990), 2003–2010.
31. Mastorakos, G., Pavlatou, M., amanti-Kandarakis, E., Chrousos, G.P., Exercise and the stress system. Hormones (Athens) 4 (2005), 73–89.
32. Mathur, N., Pedersen, B.K., Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm., 2008, 2008, 109502.
33. Mebius, R.E., Kraal, G., Structure and function of the spleen. Nat. Rev. Immunol. 5 (2005), 606–616.
34. Moldoveanu, A.I., Shephard, R.J., Shek, P.N., Exercise elevates plasma levels but not gene expression of IL-1beta, IL-6, and TNF-alpha in blood mononuclear cells. J. Appl. Physiol. 89 (2000), 1499–1504.
35. Mueller, P.J., Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity. Clin. Exp. Pharmacol. Physiol. 34 (2007), 377–384.
36. Nielsen, H.B., Secher, N.H., Kristensen, J.H., Christensen, N.J., Espersen, K., Pedersen, B.K., Splenectomy impairs lymphocytosis during maximal exercise. Am. J. Physiol. 272 (1997), R1847–R1852.
37. O'Brien, D.P., Briles, D.E., Szalai, A.J., Tu, A.H., Sanz, I., Nahm, M.H., Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections. Infect. Immun. 67 (1999), 595–601.
38. Pedersen, B.K., Hoffman-Goetz, L., Exercise and the immune system: regulation, integration, and adaptation. Physiol. Rev. 80 (2000), 1055–1081.
39. Petersen, A.M., Pedersen, B.K., The anti-inflammatory effect of exercise. J. Appl. Physiol. (1985) 98 (2005), 1154–1162.
40. Petersen, A.M., Pedersen, B.K., The role of IL-6 in mediating the anti-inflammatory effects of exercise. J. Physiol. Pharmacol. 57:Suppl. 10 (2006), 43–51.
41. Petrovsky, N., Aguilar, J.C., Vaccine adjuvants: current state and future trends. Immunol. Cell Biol. 82 (2004), 488–496.
42. Petrovsky, N., Harrison, L.C., The chronobiology of human cytokine production. Int. Rev. Immunol. 16 (1998), 635–649.
43. Rontgen, P., Sablotzki, A., Simm, A., Silber, R.E., Czeslick, E., Effect of catecholamines on intracellular cytokine synthesis in human monocytes. Eur. Cytokine Netw. 15 (2004), 14–23.
44. Rouppe, v.d.V, Kavelaars, A., van de, P.M., Heijnen, C.J., Neuroendocrine mediators up-regulate alpha1b- and alpha1d-adrenergic receptor subtypes in human monocytes. J. Neuroimmunol. 95 (1999), 165–173.
45. Sanders, V.M., Straub, R.H., Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav. Immun. 16 (2002), 290–332.
46. Sekut, L., Champion, B.R., Page, K., Menius, J.A. Jr., Connolly, K.M., Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin. Exp. Immunol. 99 (1995), 461–466.
47. Severn, A., Rapson, N.T., Hunter, C.A., Liew, F.Y., Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J. Immunol. 148 (1992), 3441–3445.
48. Simpson, R.J., Kunz, H., Agha, N., Graff, R., Exercise and the regulation of immune functions. Prog. Mol. Biol. Transl. Sci. 135 (2015), 355–380.
49. Smart, N.A., Larsen, A.I., Le Maitre, J.P., Ferraz, A.S., Effect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failure. Cardiol. Res. Pract., 2011, 2011, 532620.
50. Spengler, R.N., Allen, R.M., Remick, D.G., Strieter, R.M., Kunkel, S.L., Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 145 (1990), 1430–1434.
51. Starkie, R., 2003. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans.
52. Starkie, R., Ostrowski, S.R., Jauffred, S., Febbraio, M., Pedersen, B.K., Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 17 (2003), 884–886.
53. Starkie, R.L., Hargreaves, M., Rolland, J., Febbraio, M.A., Heat stress, cytokines, and the immune response to exercise. Brain Behav. Immun. 19 (2005), 404–412.
54. Starkie, R.L., Rolland, J., Angus, D.J., Anderson, M.J., Febbraio, M.A., Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running. Am. J. Physiol. Cell Physiol. 280 (2001), C769–C774.
55. Strangfeld, A., Listing, J., Herzer, P., Liebhaber, A., Rockwitz, K., Richter, C., Zink, A., Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 301 (2009), 737–744.
56. van der Poll, T., Coyle, S.M., Barbosa, K., Braxton, C.C., Lowry, S.F., Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 97 (1996), 713–719.
57. van der Poll, T., Jansen, J., Endert, E., Sauerwein, H.P., van Deventer, S.J., Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect. Immun. 62 (1994), 2046–2050.
58. von Haehling, S., Genth-Zotz, S., Bolger, A.P., Kalra, P.R., Kemp, M., Adcock, I.M., Poole-Wilson, P.A., Dietz, R., Anker, S.D., Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors. Am. J. Cardiol. 95 (2005), 885–889.
59. Wiedermann, C.J., Kiechl, S., Dunzendorfer, S., Schratzberger, P., Egger, G., Oberhollenzer, F., Willeit, J., Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J. Am. Coll. Cardiol. 34 (1999), 1975–1981.
60. Zaldivar, F., Wang-Rodriguez, J., Nemet, D., Schwindt, C., Galassetti, P., Mills, P.J., Wilson, L.D., Cooper, D.M., Constitutive pro- and anti-inflammatory cytokine and growth factor response to exercise in leukocytes. J. Appl. Physiol. 100 (2006), 1124–1133.